Most drugs used to treat the types of inflammation that damages the brain in neurodegenerative diseases such as Alzheimer’s cannot get around the notorious “blood-brain barrier.” UVA researchers may have found a way around that roadblock.
Recent Articles by
February 28, 2018
January 22, 2018
UVA has discovered an unknown biological process that controls the production of red blood cells. These vital cells carry oxygen throughout the body. The discovery could help doctors develop new treatments for anemias that affect millions of people.
January 12, 2018
UVA’s Dr. Karen Ballen was the co-investigator of a study that found stem-cell transplantation was a far more effective treatment for scleroderma than the most commonly prescribed drug treatment.
December 15, 2017
A UVA researcher has made biological material glow bright and red, with big benefits for cancer research, drug development and more.
December 14, 2017
Although brachytherapy is the best treatment for cervical cancer, it costs hospitals money, the researchers found. That may explain its declining use.
November 27, 2017
The next step: Find or design a drug that can inhibit the triggering enzyme.
November 09, 2017
UVA researchers have discovered that about 10 percent to 15 percent of prostate cancers and lymphomas have a certain genetic flaw that makes them particularly susceptible to chemotherapy and radiation – which are not always the first-choice treatments.
November 08, 2017
Unlike previous uses of focused ultrasound that employed the technology to destroy unwanted tissue, the new study is attempting to use the technology to help evoke an immune response.
October 31, 2017
The small study found that patients with Parkinson’s disease saw improvement in their tremor after being treated with focused ultrasound, and researchers are calling for a larger trial to confirm their findings.
October 30, 2017
Breastfeeding provides a protective effect even if it is not the exclusive feeding method, the researchers found.